What if you'd held FATE?
A $1,000 investment in Fate Therapeutics, Inc. (FATE) at the month-end close of 2013-10 would be worth $442 at the close of 2026-08 — -55.8% total return, dividends reinvested. The same $1,000 in the S&P 500 would be worth $4,388.
Your scenario
Result
If you'd bought $1,000 at the start of each year
Value of $1,000 invested on January 1 of each year, held to 2026-08, dividends included.
Every year, $1,000 from 2013
| Year | Value of $1,000 | Year return |
|---|---|---|
| 2013 | $1,000 | — |
| 2014 | $801 | -19.9% |
| 2015 | $537 | -33.0% |
| 2016 | $400 | -25.5% |
| 2017 | $973 | +143.4% |
| 2018 | $2,043 | +110.0% |
| 2019 | $3,116 | +52.5% |
| 2020 | $14,479 | +364.6% |
| 2021 | $9,317 | -35.7% |
| 2022 | $1,607 | -82.8% |
| 2023 | $596 | -62.9% |
| 2024 | $263 | -55.9% |
| 2025 | $156 | -40.6% |
| 2026 | $422 | +170.4% |
Best and worst month-end to buy
The best single month-end close to have bought FATE was 2025-03 ($0.79): $1,000 then is $3,354 today. The worst was 2020-12 ($90.93): $1,000 then is $29.14.
FAQ
What would $1,000 in FATE be worth today?
A $1,000 investment in Fate Therapeutics, Inc. (FATE) at the start of 2013 would be worth about $442 today, a total return of -55.8%. Dividends are reinvested in these figures.
What were the best and worst years for FATE?
Fate Therapeutics, Inc. (FATE)'s strongest calendar year since 2013 was 2020, a +364.6% return — $1,000 held through that year became about $4,646 by year-end. Its weakest year was 2022, at -82.8%.
Does the calculator include dividends and splits?
Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.
How much would $100 per month in FATE have grown?
Investing $100 at the end of every month since 2013-10 would have grown to about $10,271 on $15,500 invested.
Did FATE beat the S&P 500?
Over the same period, $1,000 in the S&P 500 index would be worth $4,388. FATE trailed the S&P 500 by +89.9% in total return.
Is this investment advice?
No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.
Methodology
Fate Therapeutics, Inc. (FATE) historical total-return data from 2013-10 to 2026-08, reduced to month-end closes for the tables above.
Returns use adjusted close prices from Yahoo Finance historical data — adjusted for stock splits and reinvested dividends — the same convention used by major brokerages. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (Yahoo Finance): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.
Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.
What if you'd held…
Data: adjusted close prices via Yahoo Finance. As of 2026-08. Not financial advice.